Copyright: ©Author(s) 2026.
World J Stem Cells. Jul 26, 2026; 18(7): 119714
Published online Jul 26, 2026. doi: 10.4252/wjsc.119714
Published online Jul 26, 2026. doi: 10.4252/wjsc.119714
Table 1 Comparison of clinical data of esophageal squamous cell carcinoma patients with different miR-375 and miR-655 expression levels, mean ± SD/n (%)
| miR-375 | miR-665 | |||||||
| High (n = 156) | Low (n = 156) | t/χ2 | P value | High (n = 156) | Low (n = 156) | t/χ2 | P value | |
| Sex | 0.014 | 0.904 | 0.041 | 0.839 | ||||
| Male | 105 (67.31) | 104 (66.67) | 101 (64.74) | 108 (69.23) | ||||
| Female | 51 (32.69) | 52 (33.33) | 55 (35.26) | 48 (30.77) | ||||
| Age (years) | 61.88 ± 8.61 | 60.58 ± 7.98 | 1.392 | 0.165 | 61.97 ± 8.74 | 60.49 ± 7.82 | 1.585 | 0.114 |
| BMI (kg/m2) | 22.49 ± 2.34 | 22.64 ± 2.15 | 0.567 | 0.571 | 22.42 ± 2.38 | 22.72 ± 2.10 | 1.190 | 0.235 |
| Smoking | 0.628 | 0.428 | 0.321 | 0.571 | ||||
| Yes | 76 (48.72) | 83 (53.21) | 77 (49.36) | 82 (51.56) | ||||
| No | 80 (51.28) | 73 (46.79) | 79 (50.64) | 74 (47.44) | ||||
| Alcohol | 0.000 | 1.000 | 0.218 | 0.641 | ||||
| Yes | 59 (37.82) | 59 (37.82) | 61 (39.10) | 57 (35.54) | ||||
| No | 97 (62.18) | 97 (62.18) | 95 (60.90) | 99 (63.46) | ||||
| Family cancer history | 0.502 | 0.478 | 0.126 | 0.723 | ||||
| Yes | 20 (12.82) | 16 (10.26) | 19 (12.18) | 17 (10.90) | ||||
| No | 136 (87.18) | 140 (89.74) | 137 (87.82) | 139 (89.10) | ||||
| Tumor site | 0.580 | 0.748 | 0.874 | 0.646 | ||||
| Upper | 27 (17.31) | 23 (14.74) | 27 (17.31) | 23 (14.74) | ||||
| Middle | 50 (32.05) | 48 (30.77) | 51 (32.69) | 47 (30.13) | ||||
| Lower | 79 (50.64) | 85 (54.49) | 78 (50.00) | 86 (55.13) | ||||
| Tumor diameter (cm) | 4.81 ± 1.17 | 4.68 ± 1.16 | 0.990 | 0.323 | 4.82 ± 1.17 | 4.68 ± 1.16 | 1.097 | 0.274 |
| Tumor differentiation | 6.785 | 0.009a | 10.790 | 0.001a | ||||
| Moderate-high | 91 (58.33) | 68 (43.59) | 94 (60.26) | 65 (41.67) | ||||
| Poor | 65 (41.67) | 88 (56.41) | 62 (39.74) | 91 (58.33) | ||||
| TNM stage | 7.630 | 0.006a | 5.197 | 0.023a | ||||
| Stage I-II | 76 (48.72) | 52 (33.33) | 79 (50.64) | 59 (37.82) | ||||
| Stage III-IV | 80 (51.28) | 104 (66.67) | 77 (49.36) | 97 (62.18) | ||||
| Lymph node metastasis | 4.484 | 0.034a | 8.207 | 0.004a | ||||
| Yes | 102 (65.38) | 119 (76.28) | 99 (63.46) | 122 (78.21) | ||||
| No | 54 (34.62) | 37 (23.72) | 57 (36.54) | 34 (21.79) | ||||
| Preoperative CEA (ng/mL) | 3.10 ± 1.45 | 2.99 ± 1.45 | 0.694 | 0.488 | 3.08 ± 1.49 | 3.01 ± 1.41 | 0.420 | 0.675 |
| Preoperative CA199 (U/mL) | 18.57 ± 6.90 | 18.20 ± 7.02 | 0.467 | 0.641 | 18.69 ± 6.90 | 18.08 ± 7.01 | 0.780 | 0.436 |
Table 2 Predictive efficiency of multivariate Cox regression model for progression-free survival among different time
| Time node (year) | AUC | 95%CI | Sensitivity (%) | Specificity (%) | Youden index |
| 1 | 0.605 | 0.504-0.721 | 67.9 | 51.4 | 0.193 |
| 3 | 0.651 | 0.588-0.716 | 66.0 | 62.5 | 0.285 |
| 5 | 0.662 | 0.596-0.724 | 60.8 | 68.5 | 0.293 |
- Citation: Wang JL, Niu YX, Li HX, Cui FC, Chen X. Clinical significance of mesenchymal stem cells exosomal microRNAs in predicting prognosis and inflammatory response of esophageal cancer. World J Stem Cells 2026; 18(7): 119714
- URL: https://www.wjgnet.com/1948-0210/full/v18/i7/119714.htm
- DOI: https://dx.doi.org/10.4252/wjsc.119714